31 Mar 2021
Assets58.39
Total Income28.64
Profit After Tax5.01
NET Worth10.70
Reserves and Surplus9.36
Total Borrowing38.71
At a glance
Updated 2026-09-16The shares listed at ₹135.00, a 2.27% move from the issue price. Unihealth Consultancy is a SME IPO with an issue size of ₹56.55 crore, proposed for listing on NSE SME. The offer opens on 8th Sep 2023 and closes on 12th Sep 2023. The issue structure includes a fresh issue of ₹53.70 crore. The current listing schedule points to 21st Sep 2023.
Issue details
Listing atNSE SME
Issue typeBook Build Issue
Issue size₹56.55 Cr
Fresh issue₹53.70 Cr
Face value₹10
Price band₹126.00–₹132.00
Allotment15th Sep 2023
Listing21st Sep 2023
Listing performance
Full performance ↗Issue price₹132.00
Listing price₹135.00
Current price—
Listing gain2.27%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹16.00
GMP / upper price12.12%
Est. listing₹148.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens8th Sep 2023
Closes12th Sep 2023
Allotment15th Sep 2023
Refund18th Sep 2023
Demat20th Sep 2023
Listing21st Sep 2023
Subscription demand
Full bidding ↗Total24.62×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 1000 | ₹132,000 |
Company
Incorporated2010
Use of proceeds
| Object | Amount |
|---|---|
| Investment in our joint venture, Victoria Hospital Limited (VHL), Kampala, Uganda for funding its capital expenditure requirements for proposed expansion and working capital requirements of VHL | ₹17.00 Cr |
| Investment in our joint venture, UMC Global Health Limited (UMCGHL), Nigeria for funding its capital expenditure requirements for proposed expansion; | ₹4.60 Cr |
| Investment in our subsidiary, Biohealth Limited (BL), Tanzania for funding its capital expenditure requirements for proposed expansion; and | ₹15.88 Cr |
| General corporate purposes | ₹10.93 Cr |
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue46.03₹ Cr · +21.4% vs prior year
PAT7.68₹ Cr · +101.0% vs prior year
Assets78.33₹ Cr · +20.9% vs prior year
Net Worth26.13₹ Cr · +76.7% vs prior year
Borrowing39.27₹ Cr · +3.3% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2022
Assets64.79
Total Income37.93
Profit After Tax3.82
NET Worth14.79
Reserves and Surplus13.45
Total Borrowing38.01
31 Mar 2023
Assets78.33
Total Income46.03
Profit After Tax7.68
NET Worth26.13
Reserves and Surplus26.13
Total Borrowing39.27
KPIs
| KPI |
|---|
| ROE |
| ROCE |
| Debt / Equity |
| RoNW |
| PAT Margin |
Valuation & shareholding
Pre-IPO EPS6.94
Pre-IPO P/E19.02
Post-IPO P/E26.56
Promoter holding pre95.32%
Promoter holding post68.8%
Market cap₹203.28 Cr.
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Unihealth Consultancy IPO | — | 26.56 x | — | — |
| Abh Healthcare IPO | — | 20.69 x | — | — |
| Credent Connect IPO | — | 153.66 x | — | — |
| H. R. IPO | — | 17.53 x | — | — |
Issue expenses
| Expense | Amount |
|---|---|
| Issue relating expenses such as fees to Book Running Lead Manager Fixed Fee, Registrar to the Issue, Legal Advisors, Auditors, statutory advertisements and other expenses incurred / to be incurred including promotional expenses | ₹1.72 Cr |
| Selling and marketing fees, Underwriting commission, brokerage (including Commission/ processing fees for SCSBs, Sponsor Bank, Members of the Syndicate, Registered Brokers, RTAs and CDPs | ₹6.06 Cr |
| Listing fees, Stock Exchange processing/ listing fees, software fees, Depositories’ fees, other regulatory expenses and sundry expenses | ₹0.36 Cr |
Registrar & lead managers
Registrar
Bigshare Services Pvt.Ltd.Lead managers
- Unistone Capital Pvt.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-16.
IPO UPDATE ALERTS
Register for IPO Updates →Track Unihealth Consultancy without missing an update
Register for subscription, GMP, allotment and listing notifications.